Tianjin Tianyao Pharmaceuticals Co., Ltd. (SHA:600488)

SHA:600488 Revenue

Tianjin Tianyao Pharmaceuticals had revenue of 704.94M CNY in the quarter ending June 30, 2026, a decrease of -12.17%. This brings the company's total for the last twelve months to 2.63B, down -12.32% year-over-year. In the year 2025, Tianjin Tianyao Pharmaceuticals had annual revenue of 2.91B, down -9.56%. That makes Tianjin Tianyao Pharmaceuticals the 12,654th largest company in the world by revenue and 2,178th in China.

• Revenue (ttm): 2.63B
• Revenue Growth: -12.32%
• P/S Ratio: 2.22
• Revenue / Employee: 930.32K
• Employees: 2,731
• Market Cap: 5.65B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Export 939.97M 32.5%
• East China 790.77M 27.4%
• Southern China 786.30M 27.2%
• North China 373.21M 12.9%

Fiscal year ended Dec 31, 2025 See the full SHA:600488 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.91B	-307.25M	-9.56%
Dec 31, 2024	3.22B	-567.54M	-15.00%
Dec 31, 2023	3.78B	93.90M	2.55%
Dec 31, 2022	3.69B	-59.73M	-1.59%
Dec 31, 2021	3.75B	631.82M	20.27%

Data Source: S&P Global Market Intelligence Last updated: Aug 25, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error